Skip to main content

How is atezolizumab (Tecentriq) administered?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Sep 28, 2020.

Official Answer

by Drugs.com

Atezolizumab (brand name: Tecentriq) is given by a slow intravenous (IV) infusion into your vein, usually once every 2, 3 or 4 weeks. Your initial infusion may last 60 minutes, and infusion times after this may be reduced to 30 minutes, based on your tolerability. A health care provider will give you this infusion, often in a clinic setting.

Your doctor will determine how long to treat you with atezolizumab. You will typically keep using this medicine until your disease worsens or you have side effects that require you to stop treatment.

You may be given other medications as part of your treatment regimen, either given at the clinic or to take at home. Take these medicines exactly as prescribed by your doctor.

How is atezolizumab (Tecentriq) used in cancer?

Atezolizumab is approved to treat several different types of cancer. It’s effectiveness and your length of response will depend upon your diagnosis, previous treatments, and other medical conditions, among other factors. Cancer treatment is always individualized for each patient.

Atezolizumab (Tecentriq), from Genentech, was first approved in May 2016 and is used to treat:

  • advanced bladder cancer
  • advanced melanoma (skin cancer)
  • metastatic non-small cell lung cancer (NSCLC)
  • metastatic triple negative breast cancer (ER-/PR-, HER2-)
  • extensive-stage small cell lung cancer (SCLC)
  • liver cancer (hepatocellular carcinoma)

Learn More

For current Tecentriq prices, see Tecentriq Prices, Coupons and Patient Assistance Programs

For dosage information, see Atezolizumab Dosage

For more information on immune checkpoint inhibitors, see Checkpoint Inhibitors & Advanced Cancers: A Health Care Professional's Guide

Bottom Line

  • Atezolizumab (Tecentriq) is given by a slow intravenous (IV) infusion into your vein, usually once every 2, 3 or 4 weeks.
  • Your initial infusion typically lasts for 60 minutes, and infusions after this may be reduced to 30 minutes, based on your tolerability of the medicine.
  • A health care provider will give you this infusion, often in a clinic setting.

This is not all the information you need to know about atezolizumab (Tecentriq) for safe and effective use. Review the full Tecentriq information here, and discuss this information with your doctor or other health care provider.

References
  • Tecentriq (atezolizumab) [product information]. Genentech Inc. South San Francisco, CA. Accessed Sept. 28, 2020 at https://www.gene.com/download/pdf/tecentriq_prescribing.pdf
  • Tecentriq. Dosage and Administration. Drugs.com. Accessed Sept. 28, 2020 at https://www.drugs.com/pro/tecentriq.html#s-34068-7
  • Tecentriq. FDA Approval History. Drugs.com. Accessed September 28, 2020 at https://www.drugs.com/history/tecentriq.html

Related Medical Questions

Drug Information

Related Support Groups